BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 8, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 29, 2005
View Archived Issues
Senetek completes Zeatin preclinical studies
Read More
Phase II PEAK study begins for Velcade in lung cancer
Read More
Calpain: a potential target for the treatment of diabetic vascular complications
Read More
Virax advances HIV/AIDS Co-X-Gene programs
Read More
Phase III trial studies panitumumab for first-line treatment of colorectal cancer
Read More
Phase I study assesses MT-201 with Taxotere for breast cancer treatment
Read More
Gilead progresses new fixed-dose combination of Truvada and Sustiva
Read More
Encysive restructures agreement with Revotar
Read More
Maxim receives milestone payment under agreement with Myriad Genetics
Read More
Bentley and Dong Sung sign agreement for intranasal insulin in South Korea
Read More
Alzhemed phase III trial recommended to continue
Read More
Aloxi receives European approval
Read More
Daiichi terminates TZT-1027 licensing agreement with Teikoku Hormone
Read More
Dosing under way in phase I/II trial of ImmunoVEX-Trimelan
Read More
New phase I trial of TST-10088 in advanced solid tumor patients
Read More
NDA for tetrabenazine for chorea associated with Huntington's disease
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Compounds for treatment of Flaviviridae infections reported
Read More
New agents claimed for the treatment of lipoprotein disorders, obesity, etc.
Read More
Update on atosiban in the management of dysmenorrhea and preterm labor
Read More
One-year results of the RIO-Europe study support the use of rimonabant in obesity
Read More
Significant protection against HPV infection achieved with Gardasil in young women
Read More
CHEC-9 blocks sPLA2 activity in vitro and in vivo / News in Context
Read More
Effective post-exposure therapy against West Nile virus in mice
Read More
Hayashibara claims novel therapeutic agents for osteoporosis
Read More
CR-064 neutralizes procancerous actions of ARP4
Read More
Nonpeptide Smac mimetics represent a novel class of anticancer agents
Read More
Novel beta-catenin inhibitors delay the growth of colon cancer tumors in mice
Read More
